Shell Asset Management’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$20K Sell
814
-2,206
-73% -$47.5K ﹤0.01% 1039
2025
Q2
$69K Sell
3,020
-339
-10% -$7.85K ﹤0.01% 1084
2025
Q1
$75K Sell
3,359
-148
-4% -$3.44K ﹤0.01% 1070
2024
Q4
$69K Hold
3,507
﹤0.01% 1124
2024
Q3
$64K Buy
+3,507
New +$66.9K ﹤0.01% 1146
2024
Q1
$64K Sell
3,706
-435
-11% -$9.19K ﹤0.01% 1121
2023
Q4
$95K Sell
4,141
-1,259
-23% -$28.2K ﹤0.01% 1071
2023
Q3
$124K Sell
5,400
-84
-2% -$2.14K 0.01% 1036
2023
Q2
$143K Sell
5,484
-30
-0.5% -$792 0.01% 1028
2023
Q1
$152K Sell
5,514
-19
-0.3% -$502 0.01% 1014
2022
Q4
$126K Sell
5,533
-1,085
-16% -$30.2K 0.01% 1099
2022
Q3
$225K Sell
6,618
-1,754
-21% -$64.9K 0.01% 959
2022
Q2
$244K Buy
8,372
+2,945
+54% +$74.9K 0.01% 1059
2022
Q1
$145K Sell
5,427
-798
-13% -$18.8K ﹤0.01% 1231
2021
Q4
$161K Buy
+6,225
New +$155K ﹤0.01% 1257

Other funds holding PRVA

Shell Asset Management's PRVA Position: Q3 2025 in Review

Shell Asset Management reduced its Privia Health (PRVA) stake by 73% in Q3 2025, selling an estimated $47.5K and leaving 814 shares worth $20K. The position accounts for ﹤0.01% of the portfolio, ranked #1039.

Shell Asset Management first reported a position in PRVA in Q4 2021 and has held it in 15 quarters since. The position peaked at $244K in Q2 2022. 259 funds tracked by Wall St. Rank hold PRVA as of Q3 2025.

  • Shell Asset Management held 814 shares of Privia Health worth $20K as of Q3 2025.
  • Shell Asset Management sold 2,206 Privia Health shares in Q3 2025, an estimated $47.5K.
  • Privia Health made up ﹤0.01% of Shell Asset Management's portfolio in Q3 2025, its #1039 holding.
  • Shell Asset Management first reported a position in Privia Health in Q4 2021 and has held it in 15 quarters since.
  • Shell Asset Management's Privia Health position peaked at $244K in Q2 2022.
  • 259 funds tracked by Wall St. Rank held Privia Health as of Q3 2025.

Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.